Mount Sinai researchers showed that deep learning applied to standard ECGs accurately detected chronic obstructive pulmonary ...

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality globally. Effective management ...

Learn how ECG noise filtering that adapts to noise type improved QT and QRS accuracy and supports more reliable cardiac ...

AccurECG is AccurKardia's FDA-cleared Class II software as a medical device (SaMD) platform for fully automated, near real-time ECG interpretation. AccurECG provides beat-by-beat analysis, ventricular ...

PulseAI's technology, trained on large-scale ECG datasets and validated in partnership with some of the world's leading institutions across Europe and the United States, promises to bring the power of ...

Researchers at Mount Sinai in New York City say they've developed a new artificial intelligence model designed for electrocardiogram analysis. The innovative AI approach could vastly improve the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Automated ECG interpretation system gains FDA clearance ...

Cardiologs is the world’s most advanced cloud-based and Artificial Intelligence-powered ECG analysis solution to aid healthcare professionals in screening for arrhythmias such as AFib using ambulatory ...

Introduction: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS). Its diagnosis can be challenging, ...